Global varicella vaccine market is undergoing strong expansion, driven by rising childhood immunization coverage, strategic government initiatives, and advancements in vaccine formulation technology. The market, valued at USD 4.42 billion in 2024, is projected to increase to USD 4.80 billion in 2025 and accelerate toward USD 7.70 billion by 2031, reflecting a healthy CAGR of 8.4%. Ac... https://www.24lifesciences.com/varicella-vaccine-market-7996